Article Details
Retrieved on: 2024-10-24 13:56:10
Tags for this article:
Click the tags to see associated articles and topics
Excerpt
Vanguard Group Inc. now owns 7,120,417 shares of the biopharmaceutical company's stock valued at $119,694,000 after buying an additional 73,930 shares ...
Article found on: www.defenseworld.net
This article is found inside other hiswai user's workspaces. To start your own collection, sign up for free.
Sign UpAlready have an account? Log in here